News

Pictor® Holdings Inc. Secures $7.5 Million Bridge Round to Accelerate Commercialization of Targeted Proteomic Platform

June 30, 2026 SDBN Comments Off

Investment brings Pictor’s total capital raised to approximately $30 million, supporting expanded U.S. and international commercialization efforts CARLSBAD, Calif., June 30, 2026 /PRNewswire/ — Pictor Holdings Inc., a global targeted proteomic platform company headquartered in […]

Aspen Neuroscience Announces Completion of Cohort 3 and 4 Dosing in Aspiro Phase 1/2a Trial of Sasineprocel for Parkinson’s Disease

June 30, 2026 SDBN Comments Off

Advancement of commercial-ready formulation supports scalability and late-stage development SAN DIEGO, June 30, 2026 /PRNewswire/ — Aspen Neuroscience, Inc., a clinical-stage regenerative medicine biotechnology company developing personalized, autologous cell therapies, today announced… Click here to […]

MediciNova CEO Provides Shareholder Update

June 30, 2026 SDBN Comments Off

LA JOLLA, Calif., June 30, 2026 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the Standard Market of the Tokyo Stock Exchange (Code Number: 4875), today […]

EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026

June 29, 2026 SDBN Comments Off

SAN DIEGO, June 30, 2026 /PRNewswire/ — At BIO 2026, EirGenix presented its comprehensive HER2-positive breast cancer biosimilar portfolio and highlighted its integrated one-stop contract development and manufacturing organization (CDMO) service platform. The company actively […]

Scientists Identify Houston Power Plant as Dominant Source of Cloud-Forming Aerosols

June 29, 2026 SDBN Comments Off

UC San Diego scientists and colleagues pinpointed an individual coal-fired power plant in Houston, Texas, as the main source of particles most likely to encourage formation of clouds around the metropolitan area. Particles that size […]

Pivot Grants Sustain UC San Diego Research After Federal Funding Cuts

June 29, 2026 SDBN Comments Off

After the abrupt dismantling of the United States Agency for International Development (USAID) in early 2025, researchers at the School of Medicine’s Center on Gender Equity and Health were left scrambling to fulfill their ethical […]

Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Collaboration

June 28, 2026 SDBN Comments Off

Insilico Medicine will partner with SK Biopharmaceuticals to discover new artificial intelligence (AI)-based drug candidates for disorders affecting the neuroimmune area of the central nervous system (CNS), through a collaboration that could generate up to […]

Screen Reveals New Proteins That Control RNA Processing

June 26, 2026 SDBN Comments Off

Researchers at UC San Diego have developed a large-scale screening approach that identifies proteins controlling a fundamental step in gene expression known as alternative polyadenylation (APA). APA determines where an RNA molecule is cut and […]

BIO 2026: AI, federal policy impacts, and general vibes

June 26, 2026 SDBN Comments Off

This was my first year attending BIO. JPM is called the “Super Bowl of biotech,” so with delegations from dozens of countries in attendance, you might say BIO is the World Cup. The big question […]

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

June 26, 2026 SDBN Comments Off

SAN DIEGO, June 26, 2026 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for rare diseases, today announced positive five-year data from its ongoing HOPE-2 Open-Label Extension […]

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

June 26, 2026 SDBN Comments Off

Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional scientific rationale for evaluating the Hemopurifier® as a potential treatment SAN DIEGO, June 26, 2026 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a […]

California’s Unidentified Coastal Species Get a DNA Library of Their Own

June 25, 2026 SDBN Comments Off

Marine scientists have launched the first large-scale effort to genetically catalog coastal biodiversity in California. Researchers at UC San Diego’s Scripps Institution of Oceanography are co-leading the project’s San Diego field campaign, which runs through […]

STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better

June 25, 2026 SDBN Comments Off

SAN DIEGO — On the exhibition floor at the annual international BIO conference in San Diego, biotech and startup executives hummed around pavilions representing member countries and states, pausing to watch World Cup games on […]

BIO 2026: FDA Leadership Confront Workforce Losses, China Competition in Drug Development

June 25, 2026 SDBN Comments Off

SAN DIEGO — The U.S. Food and Drug Administration (FDA) is in the middle of a cultural and operational shift that goes beyond leadership changes. U.S.–China biotechnology competition is driving discussions around regulatory reform in […]

Foundational research points to new therapeutic strategies for an emerging cancer drug

June 25, 2026 SDBN Comments Off

Highlights Salk researchers investigated the impacts of entinostat, a drug that targets HDAC proteins, and found it inactivates DNA damage repair genes in pancreatic cancer cells The discovery led to new treatment strategies that pair […]

Landmark Study Demonstrates Clairyon’s AI Agent Significantly Improves Sepsis Care Compliance

June 25, 2026 SDBN Comments Off

SAN DIEGO, June 25, 2026 /PRNewswire/ — Clairyon Inc., a leader in clinical artificial intelligence and healthcare automation, today announced the publication of a groundbreaking cluster randomized quality improvement study in JAMA Network Open. The […]

???????Looking for Work? Don’t Worry About Seeming Too Eager

June 25, 2026 SDBN Comments Off

New research combining experiments with data from 11.6 million marketplace interactions suggests employers view fast replies as a positive signal — one that increases hiring likelihood. Click here to view original post Click Here to […]

STAT+: Facing a brutal run, battered vaccine makers still see cause for hope

June 25, 2026 SDBN Comments Off

SAN DIEGO — It is an unusual time to be in the vaccine business. But in the view of those gathered here at the BIO international conference this week, it’s not altogether a bleak one. […]

Impact Beyond the Numbers: New Report Examines the Life Sciences in California

June 25, 2026 SDBN Comments Off

A newly released 2026 California Life Sciences Economic Impact Report, unveiled at the BIO 2026 International Convention in San Diego on June 22-23, finds that California’s life sciences sector supported over 400,000 jobs and generated […]

Drug Targets LDL Receptor Pathway to Control Cholesterol

June 24, 2026 SDBN Comments Off

Cholesterol-related heart disease remains the leading cause of death worldwide, and while doctors have more tools than ever to treat it, many patients still can’t achieve safe cholesterol levels or can’t tolerate the side effects […]

Does iron accumulation in the brain contribute to neurodegeneration?

June 24, 2026 SDBN Comments Off

Highlights Salk scientists explore long-standing mystery of why iron that builds up in neuronal cells becomes harmful over time in neurodegenerative diseases like Alzheimer’s and Parkinson’s They find a new cellular process, named chronoferroptosis, wherein […]

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

June 24, 2026 SDBN Comments Off

SAN DIEGO — Biotechnology is entering one of the most transformative periods in its history. But, according to Biotechnology Innovation Organization (BIO) CEO John Crowley, outdated regulations, rising development costs, and global competition threaten to […]

Biosidus Expands its International Footprint Through Strategic Partnership with Mubadala Bio in the UAE

June 24, 2026 SDBN Comments Off

SAN DIEGO and BUENOS AIRES, Argentina, June 24, 2026 /PRNewswire/ — Biosidus, one of Latin America’s pioneering biotechnology companies, announced the signing of a licensing and supply agreement with Mubadala Bio, the life sciences platform […]

STAT+: A dispatch on AI from BIOtech’s big summer bash

June 24, 2026 SDBN Comments Off

You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday. I’m writing to you from […]

STAT+: At BIO, a glimpse behind Lilly and Chai’s partnership

June 24, 2026 SDBN Comments Off

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Several of my colleagues are at the BIO conference in San Diego […]

Investigational Drug Could Control Cholesterol

June 24, 2026 SDBN Comments Off

New research from UC San Diego suggests that an existing drug, previously shelved in other contexts, could help control cholesterol. Click here to view original post Click Here to Publish/Feature Your Company or Product News […]

BIO 2026: Flagship inks research collaboration with Saudi sovereign wealth fund company

June 24, 2026 SDBN Comments Off

On Tuesday afternoon at the 2026 Biotechnology Innovation Organization conference in San Diego, Flagship Pioneering announced a research collaboration with Lean Business Services within the well-appointed Saudi Arabia pavilion in the heart of the conference’s […]

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer’s Disease Testing

June 24, 2026 SDBN Comments Off

ALZpath Strengthens Market Leadership with Abbott Agreement to Help Enable Early Alzheimer’s Diagnosis at Global Scale CARLSBAD, Calif., June 24, 2026 /PRNewswire/ — ALZpath Inc., the leader in blood test-based diagnostic solutions for Alzheimer’s disease, […]

CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data

June 24, 2026 SDBN Comments Off

FDA reviewed a protocol amendment and interim safety data from the KOURAGE trial evaluating Auxora in AKI patients No comments or questions were received Confirms CalciMedica’s ability to continue clinical development of Auxora across indications […]

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

June 24, 2026 SDBN Comments Off

Single ascending dose study evaluating safety, tolerability, and pharmacokinetics of VK3019 Potential to further expand Viking’s treatment options for weight loss SAN DIEGO, June 24, 2026 /PRNewswire/ — Viking Therapeutics, Inc. (“Viking”) (NASDAQ: VKTX), a […]

Pictor® Holdings Inc. Secures $7.5 Million Bridge Round to Accelerate Commercialization of Targeted Proteomic Platform

Aspen Neuroscience Announces Completion of Cohort 3 and 4 Dosing in Aspiro Phase 1/2a Trial of Sasineprocel for Parkinson’s Disease

MediciNova CEO Provides Shareholder Update

EirGenix Showcases Dual-Track Biosimilars and CDMO Strategy in U.S. Market Push at BIO 2026

Scientists Identify Houston Power Plant as Dominant Source of Cloud-Forming Aerosols

Pivot Grants Sustain UC San Diego Research After Federal Funding Cuts

Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Collaboration

Screen Reveals New Proteins That Control RNA Processing

BIO 2026: AI, federal policy impacts, and general vibes

Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference

Aethlon Medical Announces Publication Demonstrating Novel Long COVID Biomarker and Potential Therapeutic Target for the Hemopurifier®

California’s Unidentified Coastal Species Get a DNA Library of Their Own

STAT+: At BIO 2026, industry wrestled with Washington politics, and making AI work better

BIO 2026: FDA Leadership Confront Workforce Losses, China Competition in Drug Development

Foundational research points to new therapeutic strategies for an emerging cancer drug

Landmark Study Demonstrates Clairyon’s AI Agent Significantly Improves Sepsis Care Compliance

???????Looking for Work? Don’t Worry About Seeming Too Eager

STAT+: Facing a brutal run, battered vaccine makers still see cause for hope

Impact Beyond the Numbers: New Report Examines the Life Sciences in California

Drug Targets LDL Receptor Pathway to Control Cholesterol

Does iron accumulation in the brain contribute to neurodegeneration?

BIO 2026: CEO Calls for U.S. Biotech Urgency and International Competitiveness

Biosidus Expands its International Footprint Through Strategic Partnership with Mubadala Bio in the UAE

STAT+: A dispatch on AI from BIOtech’s big summer bash

STAT+: At BIO, a glimpse behind Lilly and Chai’s partnership

Investigational Drug Could Control Cholesterol

BIO 2026: Flagship inks research collaboration with Saudi sovereign wealth fund company

ALZpath Signs Global Licensing Agreement with Abbott to Advance Blood-Based Alzheimer’s Disease Testing

CalciMedica Announces Clinical Development of Auxora May Proceed Following FDA Review of KOURAGE Trial Interim Safety Data

Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy Adults

Want to Save Time?

Get Weekly/Trending/Daily News & Jobs Delivered to Your Inbox